A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
NCT05377996
This study is recruiting at 26 US sites in 17 states, according to its ClinicalTrials.gov record last updated .
Summary
A Study of Emi-Le in Participants with Solid Tumors
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Triple Negative Breast Cancer
- Breast Cancer
- Endometrial Cancer
- Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Cavity Cancer
- Adenoid Cystic Carcinoma
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Day One Biopharmaceuticals, Inc.
- Last updated on ClinicalTrials.gov
- June 29, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Mayo Clinic Comprehensive Cancer Center · Phoenix, AZ
California · 3
- UC Irvine Health-Chao Family Comprehensive Cancer Center · Orange, CA
- UCSF Helen Diller Family Comprehensive Cancer Center · San Francisco, CA
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology · Santa Monica, CA
Florida · 3
- Mayo Clinic - Jacksonville · Jacksonville, FL
- Florida Cancer Specialists · Sarasota, FL
- Moffitt Cancer Center · Tampa, FL
Georgia · 1
- Winship Cancer Institute, Emory University · Atlanta, GA
Illinois · 1
- Northwestern University · Chicago, IL
Massachusetts · 2
- Beth Israel Deaconess Medical Center · Boston, MA
- Dana-Farber Cancer Institute · Boston, MA
Michigan · 1
- Henry Ford Health Hospital · Detroit, MI
Minnesota · 1
- Mayo Clinic - Rochester · Rochester, MN
Nevada · 1
- Comprehensive Cancer Centers of Nevada · Las Vegas, NV
New York · 3
- ICHAN School of Medicine at Mount Sinai · New York, NY
- Memorial Sloan Kettering Cancer Center · New York, NY
- New York University Langone Health · New York, NY
Oklahoma · 1
- Stephenson Cancer Center Oklahoma University Health · Oklahoma City, OK
South Dakota · 1
- Avera Cancer Institute · Sioux Falls, SD
Tennessee · 1
- Sarah Cannon Research Institute (SCRI) · Nashville, TN
Texas · 2
- Texas Oncology, P.A. · Dallas, TX
- MD Anderson · Houston, TX
Utah · 1
- Huntsman Cancer Institute · Salt Lake City, UT
Virginia · 1
- NEXT Oncology Virginia · Fairfax, VA
Washington · 2
- Fred Hutchinson Cancer Center · Seattle, WA
- Summit Cancer Centers · Spokane, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.